TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma

BACKGROUND: Currently definitive 5-fluorouracil (5-FU)/cisplatin (CDDP) -based chemotherapy is recognized as one of the most promising treatments for esophageal cancer. A series of studies performed found genetic polymorphisms and the plasma concentration of 5-FU to be predictive of acute severe tox...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwahara, Akiko, Yamamori, Motohiro, Fujita, Megumi, Okuno, Tatsuya, Tamura, Takao, Kadoyama, Kaori, Okamura, Noboru, Nakamura, Tsutomu, Sakaeda, Toshiyuki
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915971/
https://www.ncbi.nlm.nih.gov/pubmed/20646319
http://dx.doi.org/10.1186/1756-9966-29-100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2915971/
https://www.ncbi.nlm.nih.gov/pubmed/20646319
http://dx.doi.org/10.1186/1756-9966-29-100

Ejemplares similares